BSE filing, NSE: NORRIS. Summary written from the filing by ALFA Finder's alert engine.
Norris Medicines Ltd: key numbers
- Share price
- ₹14.12
- Market cap
- ₹14.12 Cr
- Revenue (annual)
- ₹8.13 Cr
- Net profit (annual)
- ₹-0.28 Cr
- P/E (TTM)
- -38.5×Sector 45.9×
- Promoter holding
- 34.01%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Norris Medicines Ltd
All →Norris Medicines Other Announcement
Norris Medicines Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Norris Medicines Annual General Meeting
Norris Medicines Limited held its 35th Annual General Meeting on September 29, 2026, where members transacted various ordinary and special business items.
Norris Medicines Annual Report
Norris Medicines Limited has filed its 35th Annual Report for the financial year 2025-26, including the notice of its upcoming Annual General Meeting.
Norris Medicines Annual General Meeting
Norris Medicines approved the Directors' Report, Annual Report, and convening of the 35th Annual General Meeting for September 29, 2026.
Norris Medicines Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens
Norris Medicines Ltd reported revenue from operations of ₹0.9 Cr (-40.0% YoY) and a net loss of ₹0.4 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.4 Cr
Norris Medicines Management Change
Norris Medicines Limited has appointed Mr. Iqubal Ismail Patel as the Chief Financial Officer and Key Managerial Personnel, effective July 30, 2026.
Other board meeting date announcements
All →Mold-Tek Technologies Board Meeting Date
Mold-Tek Technologies will hold a board meeting on November 4, 2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Filtron Engineers Board Meeting Date
Filtron Engineers meets on 04 Nov 2026 to consider unaudited standalone and consolidated quarterly results. Trading window closed from 01 Oct 2026.
Shree Rajasthan Syntex Board Meeting Date
Shree Rajasthan Syntex Ltd has scheduled a board meeting on November 5, 2026, to approve the standalone unaudited financial results for the quarter and half-year.
Richa Info Systems Board Meeting Date
Richa Info Systems rescheduled its board meeting from 30 October to 6 November 2026 due to unavoidable circumstances. Agenda proposes fund raising through preferential or rights issue.
Signatureglobal (India) Board Meeting Date
Signatureglobal (India) has scheduled a board meeting on November 5, 2026, to consider unaudited standalone and consolidated results for Q2 and H1 FY2026-27. The trading window stays closed until November 7, 2026.
Mahasagar Travels Board Meeting Date
Mahasagar Travels will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window opened 1 October 2026.